Fibrogen Inc. buy StockNews.com
Start price
10.03.23
/
50%
€18.87
Target price
10.03.24
-
Performance (%)
-91.41%
End price
11.03.24
€1.62
Summary
This prediction ended on 11.03.24 with a price of €1.62. Massive losses of -91.41% were the result for the BUY prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fibrogen Inc. | - | - | - | - |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by StockNews_com for this prediction
In the thread Fibrogen Inc. diskutieren
FibroGen, Inc. (NASDAQ: FGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FGEN provided by MarketBeat
In the thread Trading Fibrogen Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten